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SUPPLEMENTARY METHODS

RNA FISH and Immunostaining.
Cells were fixed in 4% PFA/PBS at 4°C and washed three times in PBS followed by permeabilization in 2% prechilled acetone/PBS for 5 min. Pre-hybridization was performed in 30% formamide and 2xSSC buffer for 10 min followed by hybridization in a buffer containing 30% formamide, 2xSSC, 0.02% BSA, 66 µg/ml yeast tRNA, 10% dextran sulfate, 2 mM vanadyl ribonucleoside complex and 2 ng/µl DNA/LNA probes (CAG) 6 -CA labeled at the 5′-end with Cy3 and modified at positions 2, 5, 8, 13, 16 and 19 with LNA. Post-hybridization washing was performed in 30% formamide and 2xSSC at 45°C for 30 min followed by 1xSSC at 37°C for the next 30 min.
Slides were either mounted in SlowFade Gold antifade reagent with DAPI (Invitrogen) for CUG exp RNA foci analysis or used for subsequent IF. For RNA FISH in combination with IF, the slides were incubated in blocking buffer (5% non-fat milk, 10% normal serum and 0.3% Triton X-100 in PBS) for 1 h at room temperature and treated with rabbit anti-MBNL1 primary antibody (A2764) overnight at 4°C. Afterwards, the slides were washed in PBS three times for 5 min each and then incubated with a secondary anti-rabbit antibody conjugated to Alexa Fluor 488 (Molecular Probes). Following three PBS washes, the slides were mounted in the antifade reagent containing DAPI.
Filter binding assay.
Preparation of (CUG) Recombinant . GST fusion with the 41 kDa MBNL1 isoform sequence encoded by exons 1-4 of the MBNL1 gene (NP_066368) with a His6 tag at the C-terminus was prepared using BL21(DE3) cells containing the pGEX-6P-MBNL1-Δ105-His-Δ105-PL vector. Protein production was induced when 0.5 L of bacterial culture reached 0.5 OD by adding 250 µM IPTG at 37°C for 4 h. Cells were collected by centrifugation at 5,000 rpm for 10 min at 4°C and resuspended in 25 ml of lysis buffer containing 35 mM Tris-HCl (pH 8.0), 500 mM NaCl, 5 mM imidazole, 5% glycerol, and 0.1% Tween-20 with the addition of 1 mM PMSF, 2 mg lysozyme, 133 µg RNase A and 150 U DNase. Cells were lysed at 4°C by sonication (12-times for 30 sec each).
The collected supernatant was centrifuged at 19,000 rpm for 20 min. The protein was purified using a HisTrap FF
Crude column (GE Healthcare) on an FPLC system and PD-10 columns (GE Healthcare) following the manufacturer's protocols, and the total protein concentration was measured by the Bradford assay. Protein (1.5 µM)
was stored at -20°C in 50 % glycerol and buffer containing 50 mM Tris (pH 8.0), 50 mM KCl, 300 mM NaCl, 1 mM MgCl 2 and 0.02% Tween-20. Representative agarose gel images of RT-PCR products of several pre-mRNAs regulated by NOVA1, FOX2, PTBP1 and PTBP2 in DM1 human myoblasts after the treatment with C16 and C51 at indicated concentrations. No changes in the splicing pattern were detected upon the treatments with the exception of PPP3CB. Numbers below the gels indicate the ratio between bands representing exon exclusion to the total intensity of both splice products.
